Call made for anti-inflammatory systemic Tx

Berlin - New therapeutic modalities are needed for treating thesubstantial population of acne patients with marked inflammatory diseaseand scarring. Available data indicate compounds with selective anti-inflammatoryactivity may help fill that niche, Christos C. Zouboulis, M.D., said.

Related Videos
Related Content

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

New Advancements in Surgical Scar Revision

March 19th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

New Advancements in Surgical Scar Revision

March 19th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Ruxolitinib Cream Maintains Disease and Symptom Control in Adults and Adolescents With AD

March 19th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

RAPID3 Scores May Help Determine the Impact of DMARD Therapy on PsA Severity

March 19th 2023

New Advancements in Surgical Scar Revision

March 19th 2023
© 2023 MJH Life Sciences

All rights reserved.